A comprehensive view of home use/self-care. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis reports combination of Kisqali ribociclib and fulvestrant offer survival benefit of almost 16 months in previously untreated breast cancer versus fulvestrant alone; Kisqali is approved in more than 95 countries to treat breast cancer
Published: May 13, 2022 by SeeNews Pharmaceuticals
Global IVD contract manufacturing market projected to grow from US$4.6B in 2021 to US$5.6B by 2026; growth driven by increasing demand for point-of-care diagnostics in clinic, hospital, office, home settings
Published: May 12, 2022 by Financial Services Monitor Worldwide
FDA approves BLA 125521 for Eli Lilly’s Taltz injectable containing ixekizumab 80 mg/mL in one formulation to treat autoimmune disease; the drug is available by prescription only and has no therapeutic equivalents
Published: May 12, 2022 by US Food and Drug Administration News (CBNB Abstracts)
Stevanato named exclusive manufacturer of Owen Mumford’s Aidaptus two-step, single-use auto-injector that automatically adapts to fill volume; device joins Stevanato’s portfolio of pen injector, auto-injector, inhaler, wearable delivery system
Published: May 11, 2022 by FiercePharma
Tandem Diabetes Care Q1 net loss widens to US$14.7M from US$5.0M a year ago, with sales up 25% year-over-year to US$175.9M; FDA clears t:slim X2 insulin pump to bolus with t:connect mobile app, with global pump shipments growing 11% to 28,095 pumps
Published: May 10, 2022 by Tandem Diabetes Care, Inc.

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count